Magellan to Bring Miacom's Sepsis Tests to the US, Canada

Magellan anticipates marketing a family of Miacom sepsis tests in the US for research use only, while starting clinical trials in preparation of submission to the US Food and Drug Administration.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories